188 related articles for article (PubMed ID: 34570228)
41. Small-Molecule Inhibitors of the SOX18 Transcription Factor.
Fontaine F; Overman J; Moustaqil M; Mamidyala S; Salim A; Narasimhan K; Prokoph N; Robertson AAB; Lua L; Alexandrov K; Koopman P; Capon RJ; Sierecki E; Gambin Y; Jauch R; Cooper MA; Zuegg J; Francois M
Cell Chem Biol; 2017 Mar; 24(3):346-359. PubMed ID: 28163017
[TBL] [Abstract][Full Text] [Related]
42. ZBP-89 and Sp3 down-regulate while NF-Y up-regulates SOX18 promoter activity in HeLa cells.
Petrovic I; Kovacevic-Grujicic N; Stevanovic M
Mol Biol Rep; 2009 May; 36(5):993-1000. PubMed ID: 18496767
[TBL] [Abstract][Full Text] [Related]
43. Structure and decoy-mediated inhibition of the SOX18/Prox1-DNA interaction.
Klaus M; Prokoph N; Girbig M; Wang X; Huang YH; Srivastava Y; Hou L; Narasimhan K; Kolatkar PR; Francois M; Jauch R
Nucleic Acids Res; 2016 May; 44(8):3922-35. PubMed ID: 26939885
[TBL] [Abstract][Full Text] [Related]
44. SOX18 and the transcriptional regulation of blood vessel development.
Downes M; Koopman P
Trends Cardiovasc Med; 2001 Nov; 11(8):318-24. PubMed ID: 11728880
[TBL] [Abstract][Full Text] [Related]
45. Cloning and functional analysis of the Sry-related HMG box gene, Sox18.
Hosking BM; Wyeth JR; Pennisi DJ; Wang SC; Koopman P; Muscat GE
Gene; 2001 Jan; 262(1-2):239-47. PubMed ID: 11179689
[TBL] [Abstract][Full Text] [Related]
46. Mutations in Sox18 underlie cardiovascular and hair follicle defects in ragged mice.
Pennisi D; Gardner J; Chambers D; Hosking B; Peters J; Muscat G; Abbott C; Koopman P
Nat Genet; 2000 Apr; 24(4):434-7. PubMed ID: 10742113
[TBL] [Abstract][Full Text] [Related]
47. Dominantly inherited glomerulonephritis and an unusual skin disease.
Sherwood MC; Pincott JR; Goodwin FJ; Dillon MJ
Arch Dis Child; 1987 Dec; 62(12):1278-80. PubMed ID: 3435166
[TBL] [Abstract][Full Text] [Related]
48. APCDD1 is a novel Wnt inhibitor mutated in hereditary hypotrichosis simplex.
Shimomura Y; Agalliu D; Vonica A; Luria V; Wajid M; Baumer A; Belli S; Petukhova L; Schinzel A; Brivanlou AH; Barres BA; Christiano AM
Nature; 2010 Apr; 464(7291):1043-7. PubMed ID: 20393562
[TBL] [Abstract][Full Text] [Related]
49. Sox7 controls arterial specification in conjunction with hey2 and efnb2 function.
Hermkens DM; van Impel A; Urasaki A; Bussmann J; Duckers HJ; Schulte-Merker S
Development; 2015 May; 142(9):1695-704. PubMed ID: 25834021
[TBL] [Abstract][Full Text] [Related]
50. Genetic ablation of SOX18 function suppresses tumor lymphangiogenesis and metastasis of melanoma in mice.
Duong T; Proulx ST; Luciani P; Leroux JC; Detmar M; Koopman P; Francois M
Cancer Res; 2012 Jun; 72(12):3105-14. PubMed ID: 22523034
[TBL] [Abstract][Full Text] [Related]
51. SOX18 Is a Novel Target Gene of Hedgehog Signaling in Cervical Carcinoma Cell Lines.
Petrovic I; Milivojevic M; Popovic J; Schwirtlich M; Rankovic B; Stevanovic M
PLoS One; 2015; 10(11):e0143591. PubMed ID: 26588701
[TBL] [Abstract][Full Text] [Related]
52. Control of the SOST bone enhancer by PTH using MEF2 transcription factors.
Leupin O; Kramer I; Collette NM; Loots GG; Natt F; Kneissel M; Keller H
J Bone Miner Res; 2007 Dec; 22(12):1957-67. PubMed ID: 17696759
[TBL] [Abstract][Full Text] [Related]
53. [Primary lymphedema of limbs].
Vaillant L; Tauveron V
Presse Med; 2010 Dec; 39(12):1279-86. PubMed ID: 21035299
[TBL] [Abstract][Full Text] [Related]
54. Adipose tissue-derived stromal cells acquire endothelial-like features upon reprogramming with SOX18.
Fontijn RD; Favre J; Naaijkens BA; Meinster E; Paauw NJ; Ragghoe SL; Nauta TD; van den Broek MA; Weijers EM; Niessen HW; Koolwijk P; Horrevoets AJ
Stem Cell Res; 2014 Nov; 13(3 Pt A):367-78. PubMed ID: 25290189
[TBL] [Abstract][Full Text] [Related]
55. LPS-induced Acute Lung Injury Involves NF-κB-mediated Downregulation of SOX18.
Gross CM; Kellner M; Wang T; Lu Q; Sun X; Zemskov EA; Noonepalle S; Kangath A; Kumar S; Gonzalez-Garay M; Desai AA; Aggarwal S; Gorshkov B; Klinger C; Verin AD; Catravas JD; Jacobson JR; Yuan JX; Rafikov R; Garcia JGN; Black SM
Am J Respir Cell Mol Biol; 2018 May; 58(5):614-624. PubMed ID: 29115856
[TBL] [Abstract][Full Text] [Related]
56. Vascular endothelial growth factor induces MEF2C and MEF2-dependent activity in endothelial cells.
Maiti D; Xu Z; Duh EJ
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3640-8. PubMed ID: 18450586
[TBL] [Abstract][Full Text] [Related]
57. SOX18 exerts tumor-suppressive functions in papillary thyroid carcinoma through inhibition of Wnt/β-catenin signaling.
Geng Q; Deng H; Fu J; Cui F
Exp Cell Res; 2020 Nov; 396(1):112249. PubMed ID: 32858034
[TBL] [Abstract][Full Text] [Related]
58. Impact of SOX18 expression in cancer cells and vessels on the outcome of invasive ductal breast carcinoma.
Pula B; Olbromski M; Wojnar A; Gomulkiewicz A; Witkiewicz W; Ugorski M; Dziegiel P; Podhorska-Okolow M
Cell Oncol (Dordr); 2013 Dec; 36(6):469-83. PubMed ID: 24065215
[TBL] [Abstract][Full Text] [Related]
59. MEF2C loss-of-function mutation associated with familial dilated cardiomyopathy.
Yuan F; Qiu ZH; Wang XH; Sun YM; Wang J; Li RG; Liu H; Zhang M; Shi HY; Zhao L; Jiang WF; Liu X; Qiu XB; Qu XK; Yang YQ
Clin Chem Lab Med; 2018 Feb; 56(3):502-511. PubMed ID: 28902616
[TBL] [Abstract][Full Text] [Related]
60. A novel 9-amino-acid transactivation domain in the C-terminal part of Sox18.
Sandholzer J; Hoeth M; Piskacek M; Mayer H; de Martin R
Biochem Biophys Res Commun; 2007 Aug; 360(2):370-4. PubMed ID: 17603017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
